ASML: Expensive, Rare, But Still Worth Buying

ASML is rated a buy with a $2,173 price target, implying 16.6% upside from the current $1,863 share price. The thesis is driven by EUV lithography intensity, high-NA EUV adoption, installed base management, and metrology/inspection demand. The outlook also calls for EPS to rise from an estimated €30.9 in 2026 to €36.49 in 2027, supporting the positive view.

Analysis

The important second-order read-through is that ASML is less a single-company earnings story and more a leverage point on the entire leading-edge capex stack. If EUV intensity and High-NA adoption are inflecting, the beneficiaries are not just ASML shareholders but also downstream wafer-fab equipment, specialty materials, and advanced process control vendors that get pulled into the same cycle; the losers are trailing-edge foundry capacity and any logic memory players still assuming a multi-year lull in capex. In other words, this is a signal that the frontier of process complexity is getting more expensive again, which tends to widen the moat for the few tools providers with true bottleneck status.

The market may be underestimating how much of the EPS step-up can come from mix, not just unit growth. Higher service intensity, installed-base monetization, and metrology/inspection attachment rates should make earnings less cyclical than headline wafer-fab spending implies, so the valuation multiple can remain sticky even if system shipments are lumpy. The key nuance is timing: the stock can re-rate over months on confidence in 2027 EPS, while the actual earnings compounding may come in waves tied to customer qualification schedules and ASML's own delivery cadence.

The main tail risk is not demand disappearance but customer digestion. If leading-edge foundry or memory capex gets deferred by even 2-3 quarters, the market could punish the stock because it is already pricing in a cleaner 2027 ramp; that would likely show up first in backlog quality and service mix commentary rather than outright orders. A second-order risk is export policy friction: any incremental restriction on tool shipment geography would not just hit revenue, it could also change the mix toward lower-margin installed-base activity, reducing the earnings leverage the market is paying for.

Contrarian view: consensus may be too focused on the scarcity premium and not enough on the fact that the best businesses in the semiconductor equipment complex often trade at peak confidence before the next capex digestion phase. This looks more under-discounted than over-discounted if High-NA adoption is real, but the cleaner entry is likely on any post-earnings or macro-driven pullback, not after a straight-line rerating. The asymmetry is best when paired against names with similar AI exposure but weaker pricing power, because ASML's moat should translate into superior margin resilience if the cycle softens.

Key Decisions for Investors

• Go long ASML on a 1-3 month horizon, but prefer buying weakness after any 3-5% pullback; target a move toward the stated upside with a stop if backlog/service commentary deteriorates.
• Pair trade: long ASML / short a basket of higher-beta semiconductor equipment names with weaker moat or more cyclical order exposure over the next 1-2 quarters; thesis is that ASML captures the re-rating while weaker peers get punished on any capex pause.
• Add exposure to downstream beneficiaries of rising process complexity — especially metrology/inspection and advanced process control names — as a 6-12 month second-order trade if EUV intensity keeps rising.
• Use call spreads in ASML rather than outright stock if entering ahead of earnings: 3-6 month bullish structure to capture re-rating while limiting downside if customer digestion delays the 2027 EPS narrative.
• If geopolitical/export headlines hit the tape, treat any sharp selloff as a tactical buy-the-dip opportunity unless the issue clearly affects shipment mix; that kind of headline risk is likely to create better entry than a true fundamental change.